Lamotrigine Tablet, Film Coated, Extended Release
Product Images NDC 65162-949

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 65162-949). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Lamotrigine Extended Release Tablets Usp 1)

Chemical structure of lamotrigine showing a triazine ring with two amine groups and a dichlorophenyl substituent.*

FDA Label Image

25 mg (Lamotrigine Extended Release Tablets Usp 10)

Label for Lamotrigine Extended-Release Tablets, USP 300 mg by Amneal Pharmaceuticals LLC. The label indicates the product is for oral use, with 30 tablets per bottle, and highlights storage instructions between 20° to 25°C with permitted excursions. It includes a caution to verify product dispensed and a pharmacy dispensing note.*

FDA Label Image

Figure 1 (Lamotrigine Extended Release Tablets Usp 2)

A line chart comparing responder rates between Lamotrigine Extended-Release (N=70) and placebo (N=73) groups across percent of patients. The y-axis shows responder rate from worsening to improvement, and the x-axis shows percent of patients from 100 to 0. The solid line represents Lamotrigine Extended-Release, and the dashed line represents placebo, illustrating higher responder rates for Lamotrigine.*

FDA Label Image

Figure 2 (Lamotrigine Extended Release Tablets Usp 3)

A cumulative responder rate graph comparing Lamotrigine Extended-Release and placebo in a patient study. The vertical axis shows responder rate from -100% (worsening) to 100% (equal or greater improvement), while the horizontal axis represents percent of patients from 100% to 0%. Two lines display the response rates for placebo (dashed) and Lamotrigine Extended-Release (solid). The graph depicts the distribution of patient responses by treatment group.*

FDA Label Image

Q (Lamotrigine Extended Release Tablets Usp 4)

A table listing Lamotrigine extended release tablets by strength and color, including 25 mg yellow, 50 mg green, 100 mg beige, 200 mg blue, 250 mg purple, and 300 mg gray. Each strength is shown with its respective imprint codes (e.g., A 949 for 25 mg, AN 988 for 250 mg).*

FDA Label Image

W (Lamotrigine Extended Release Tablets Usp 5)

Label for Lamotrigine Extended-Release Tablets, USP 25 mg, film-coated tablets. The label indicates a 30-tablet package, distributed by Amneal Pharmaceuticals LLC. It includes cautionary storage instructions and a reminder to verify the product dispensed, with a printed safety seal warning and NDC code 65162-949-03.*

FDA Label Image

R (Lamotrigine Extended Release Tablets Usp 6)

Label for Lamotrigine Extended-Release Tablets, USP, 50 mg by Amneal Pharmaceuticals LLC. The label specifies a 30-tablet count of extended-release, film-coated tablets containing 50 mg of lamotrigine each. It includes storage instructions (20° to 25°C), caution to verify product dispensed, pharmacist directions to provide a medication guide, and a note about not using if the safety seal is broken or missing.*

FDA Label Image

Y (Lamotrigine Extended Release Tablets Usp 7)

Lamotrigine Extended-Release Tablets, USP 100 mg film coated, extended release tablets in a 30-tablet bottle. The label includes storage instructions and cautions to verify the product dispensed. Distributed by Amneal Pharmaceuticals LLC.*

FDA Label Image

N (Lamotrigine Extended Release Tablets Usp 8)

Lamotrigine Extended-Release Tablets, USP 200 mg film coated, extended-release tablets, containing 200 mg of lamotrigine each. The label shows a package of 30 tablets, marked for once-a-day use, distributed by Amneal Pharmaceuticals LLC. Important cautions and storage instructions are included, along with a barcode and NDC 65162-986-03.*

FDA Label Image

B (Lamotrigine Extended Release Tablets Usp 9)

Label for Lamotrigine Extended-Release Tablets, USP 250 mg by Amneal Pharmaceuticals LLC. The label indicates the product is a once-a-day oral extended-release film-coated tablet available in a 30-count package. Storage instructions specify 20° to 25°C, with allowable excursions up to 30°C. Safety seal warning and pharmacist dispensing instructions are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.